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DEBRA BOWEN I SECRETARY OF STATE
STATE OF CALIFORNIA ELECTIONS

I

1500 11th Street, 5th Floor I Sacramento, CA 9s814 1Tel (916) 657-2166 1Fax (916) 653-3214 lwww.sos.ca.gov

May 2,2012

County Clerk/Registrar of Voters (CC/ROV) Memorandum #12138
TO:

erks/Registrars of Voters and Proponent

FROM:
Katherine Montgomery
Initiative Program Manager
RE:

Initiative: Failure of #1523, Related to Taxes and Controlled
Substances

Pursuant to Elections Code section 9030(b), you are hereby notified that the total
number of signatures for the hereinafter named initiative statute filed with all
county elections officials is less than 100 percent of the number of qualified
voters required to find the petition sufficient; therefore, the petition has failed .

TITLE:

TAX ON CONTROLLED SUBSTANCES. INITIATIVE
STATUTE.

SUMMARY DATE: November 21 , 2011

PROPONENT:

Robert Pack

DEBRA BOWEN I SECRETARY OF STATE
STATE OF CALIFORNIA I ELECTIONS
1500 11th Street. 5th Floor ISacramento. CA 95~h41Tel (916) 657-21661 Fax (916) 6s3-32L4lwww.sos.ca.gov

November 21, 2011

County Clerk/Registrar of Voters (CC/ROV) Memorandum #11120
TO:

All County Clerks/Registrars of Voters and Proponent

FROM:
Initiative Program Marn\!~er

RE: Initiative: 1523, Related to Taxes and Controlled Substances

Pursuant to Elections Code section 9004 (c), we transmit herewith a copy of the
Title and Summary prepared by the Attorney General on a proposed initiative
measure entitled :

TAX ON CONTROLLED SUBSTANCES.
INITIATIVE STATUTE.

The proponent of the above-named measure is:

Robert Pack
(925) 918-0843
bpack@sbcglobal.net

#1523
TAX ON CONTROLLED SUBSTANCES.
INITIATIVE STATUTE.
CIRCULATING AND FILING SCHEDULE

1.

Minimum number of signatures required: .................................................... 504,760
California Constitution, Article II , Section 8(b)

2.

Official Summary Date: ............................................................... Monday, 11/21/11

3.

Petitions Sections:
a. First day Proponent can circulate Sections for
signatures (Elections Code § 336) ........................................ Monday, 11121/11
b. Last day Proponent can circulate and file with the county.
All sections are to be filed at the same time within each
county. (Elections Codes §§ 9014, 9030(a)) ........................ Thursday, 04/19/12
c. Last day for county to determine total number of
signatures affixed to petitions and to transmit total
to the Secretary of State (Elections Code § 9030(b» ............ Tuesday, 05/01/12
(If the Proponent files the petition with the county on a date prior to
04/19/1.2, the county has eight working days from the filing of the petition
to determine the total number of signatures affixed to the petition and to
transmit the total to the Secretary of State) (Elections Code § 9030(b).)
d. Secretary of State determines whether the total number
of signatures filed with all county clerks/registrars of
voters meets the minimum number of required signatures
and notifies the counties .......................... ........ ............ Thursday, 05/10/12"
e. Last day for county to determine total number of qualified
voters who signed the petition, and to transm~ certificate
with a blank copy of the petition to the Secretary of State
(Elections Code §§ 9030(d)(e)) .............................. .............. Friday, 06/22/12

* Date varies based on the date of county receipt.

INITIATIVE #1523
Circulating and Filing Schedule continued:

(If Ihe Secrelary of State nolifies Ihe county to determine Ihe number of
qualified voters who signed Ihe petilion on a date other than 05/10/12 , Ihe
lasl day is no laler Ihan the thirtieth working day after Ihe counly's receipt
of notificalion). (Eleclions Code §§ 9030(d)(e).)
f.

If the signalure count is more than 555,236 or less than
479,522 Ihen the Secretary of Slate certifies the pelition as
qualified or failed, and nolifies the counties. If the signalure
counl is between 479,522 and 555,236 inclusive, then the
Secretary of State notifies the counties using the random
sampling technique to determine the validity of all
signatures (EC §9030(f)(g); 9031 (a)) .. .. .... .. ............ .. .. ........ Monday, 07/02112"

g. Last day for county to determine actual number of all qualified
voters who signed the petition, and to transmij certificate
with a blank copy of the petition to the Secretary of State.
(Elections Code §§ 9031 (b)(c)) ............................................ Tuesday, 08114112
(If the Secretary of State notifies the county to determine the number of
qualified voters who have signed the petition on a date other than
07/02112 , the last day is no later than the thirtieth working day after the
county's receipt of notification .) (Elections Code §§ 9031(b)(c).)
h. Secretary of State certifies whether the petition has been
signed by the number of qualified voters required to declare
the petition sufficient (Elections Code §§ 9031(d), 9033) ... Saturday, 08/18112"

"'Date varies based on the date of county receipt.

IMPORTANT POINTS

•

California law prohibils the use of signatures, names and addresses
gathered on initiative petitions for any purpose other than to qualify the
initiative measure for the ballot. This means that the petitions cannot be
used to create or add to mailing lists or similar lists for any purpose,
including fund raising or requests for support. Any such misuses
constitutes a crime under California law. Elections Code § 18650;
Bilofsky v. Deukmejian (1981) 124 Cal.App.3d 825, 177 Cal.Rptr. 621;
63 Ops.CaI.Atty.Gen. 37 (1980).

•

Please refer to Elections Code §§ 100, 101, 104, 9008, 9009, 9013,
9021, and 9022 for appropriate format and type consideration in printing,
typing and otherwise preparing your initiative petition for circulation and
signatures. Please send a copy of the petition after you have it printed.
This copy is not for our review or approval, but to supplement our file.

•

Your attention is directed to the campaign disclosure requirements of the
Political Reform Act of 1974, Government Code section 81000 et seq.

•

When writing or calling state or county elections officials, provide the
official title of the initiative which was prepared by the Attorney General.
Use of this title will assist elections officials in referencing the proper file.

•

When a petition is presented to the county elections official for filing by
someone other than the proponent, the required authorization shall
include the name or names of the persons filing the petition.

•

When filing the petition with the county elections official, please provide
a blank petition for elections official use.

KAMALA D. HARRIS
Attorney General

State ofCalifornia
DEPARTMENT OF JUSTICE
1300 I STREET, SUITE 125
P.O. BOX 944255
SACRAMENTO, CA 94244·2550
Public: ~9 1 ~ 445·9555

Telepbone: 91

324-5464

Facsimile: 916 324-8835
E-Mail: DawnMcFarland@doj.ca.gQY

November 21, 2011

FILED
In (he office of the Secretary of State
of the State of California

The Honorable Debra Bowen
Secretary of State
Office of the Secretary of State
1500 11th Street, 5th Floor
. Sacramento, CA 95814

Attention:

NOV 21 2011

VI'"

"""I'fl'-

Debra ~

3:4Y!'""
tate

Ms. Katherine Montgomery
ElectioDS Analyst

Dear Secretary Bowen:
Pmsuant to Elections Code section 9094. you are hereby notified that on this day we sent our
title and summary for the following proposed initiative to the proponent:
•

11-0045, "Imposes A Fee On Drug Companies To Fund The CURES Program For Safe
.Prescribing Of Prescription Narcotics"

A copy of that title and summary and text of the proposed initiative is enclo~ed. Please .
contact me if you h~ve questions.

~~oJ~
DAWNL.MCFARLAND
Acting Initiative Coordinator

For

DLM:

cc:

Robert Pack, Proponent

KAMALAD. HARRIS
Attorney General

November 21 , 2011
Initiative 11-0045

The Attorney General of California has prepared the foll owing title and summary of the ch ief
purpose and points of the proposed measure:

TAXON CONTROLLED SUBSTANCES. INITIATIVE STATUTE. For three years
beginning January 1, 20 13, imposes a tax of$.0025 per pil l upon drug manufacturers and
importers that make initial saJe ofa Schedule II , III , or IV contro lled substance in Californ ia.
Provides revenue to fund California Department of Ju stice 's program to monitor prescription and
di spe n ~at ion

of controlled substances, administration costs, outreach, education, and

investigation of abuses. Requires any person that manufactures Schedule II, III, or IV controlled
substances in California, or imports them into California, to register with the California
Department of Justice for purposes of tax comp liance. Summary of estimate by Legislative
Analyst and Director of Finance of fi scal impact on state and local government: Increased state
revenues of approximately $7 million annually from a new tax on prescription drugs. The
revenues would be used to increase spending on a prescription drug database maintained
by DOJ. (11·0045)

11

00 45

~CE'VED
SEP 3 0 2011
To;

INITIATIVE COORDINATOR ·
ATIORNEY GENERAL'S OFFICE

Office of the Attorney Genera'i

State of California
Sept. 20, 2011
J

am requesting that the enclosed proposition be submitted for TItle and Summary for the 2012 election

year, November 6, ballot.

Submitted by

1<@fr(JttvL
Robert Pack

Email bpack@sbcglobal.net
Cell 925-918-0843

11

September 30, 2011
California State Ballot Measure / Proposition for 2012
Submitted by Robert S. Pack

Email

bpack(a),sbcglobal.net
tel 925-918-0843

Proposal for Title and Summary

SUMMARY
Imposes a tax on every manufacturer and importer, or other
person that makes the ~t sale in the state, of a
Schedule II, III or IV controlled substance, at the rate of
$0.0025 per pill. Creates a fund to support the Controlled

Substance Utilizatiori Review and Evaluation System (CURES).

CHANGES TO EXISTING LAW

Existing federal law:
Regulates the manufacture, importation, possession, use,
and distribution of certain substances, including
controlled substances. and classifies these substances by
Schedules based on a criteria which includes potential for
abuse, currently accepted medical use for.treatment in the
U.S., and international treaties.

Requires the Department of Justice (DOJ) to maintain CURES
for electronic monitoring of the prescribing and dispensing
of Schedule II,.III and lV controlled substances by all
. practitioners authorized to prescribe or dispense these
controlled substances.
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0045

Requires all practitioners authorized to prescribe or
dispense these controlled substances to report specified
information every time these controlled substances are
prescribed or dispensed.

This proposition
Imposes a tax at the rate of $0.0025 per pill included in
Schedule IT, Ill, or IV upon every manufacturer and
importer of controlled substances classified as Schedule
n, m, or IV, or other person that makes the first sale
in this state of a Schedule n, m. odV controlled
substance.
Requires the State Board of Equalization to administer and
collect the tax pursuant to the procedures set forth in the
Fee Collection Procedures Law. Requires the board to
deposit all taxes, penalties, and interest collected, less
refunds and administrative costs, in the CURES Fund, which
this proposi.tionwould create.
Requires moneys in the fund, upon appropriation by the
Legislature, to be allocated to DOJ for the cost of the
CURES program, as specified.

Requires a person that manufactures controlled substances
classified in Schedule TI, m, or IV in this suite, or
that impo~ controlled substances classified in Schedule
II. III. or IV in to this state. to register with DOl to enable the
departrrient to repOrt specified information to "the board for
purpo.ses of collecting a tax on those persons.
DOJ estimates that over 45 million prescriptions are
written annually, and two billion pills are related to
those prescriptions. The $0.0025 tax per pill included in
Schedule II. III. or IV proposed by SB 1071 is estimated by
DOJ to raise·approximately $5 million in special:fund
revenues.

Page 2

BACKGROUND AND DISCUSSION

According to the author, is a'response to the
steadily worsening prescription drug abuse crisis. The
author states that prescnption drug abuse·has serious
consequences for both abusers and the public. Each year,
hundreds of people die from prescription drug overdose and
dozens more are injur.ed or killed by prescription drug
abusers driving under the influence of medication. The
. author contends that the ".measue" will help to curb prescription
drug abuse by providing revenues to sustain the Controlled
Substance Utilization Review and Evaluation System (CURES),
which is designed to control the misuse, abuse, and

trafficking of dangerous prescription narcotics.
It is the author's intent to impose atax on Schedule n.
III and N drugs that are in the form ofpills, that will
produce roughly S5 million per year to support the CURES
progrtun.
A priority for the use of the funds would be increasing the
rate at which authorized persons access infonnation from
he CURES Internet database pertaining to prescribing
controlled substances, related to patient histories on
being prescribed controned substances.
Controlled substances
Controlled substances are drugs that have a high potential
for abuse, and are regulated by both state and federal
governnient. The federal government regulates the
mannfacture, diStribution, and dispensing of controlled
substances through the Controlled Substances Act of 1970
(Act). The Act ranks into five schedules those drugs known
to have potential for physical or psychological harm, based .
on three considerations: 1) their potential for abuse; 2)
their accepted medical use; and, 3) their accepted safety
under medical supervision.
Schedule I controlled substances have a high potential for
abuse and no generally accepted medical use such as heroin,
LSD and marijuana. Schedule n controlled substances have
a currently accepted medical use in treatment, or a
currently accepted medical use with severe restrictions,
and have a high potential for abuse and psychological or
physical dependence. Schedule n drugs can be mkcotics or
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non·narcotic. Examples of Schedule II controlled
substances include morphine. methadone. Ritalin, Demerol.
Dilaudid, Percocet, Percodan, and Oxycontin. Scbedule ill
and IV drugs include Vicodin, Zanex, Ambien and other
anti·anxiety drugs that generally have less potential for
abuse than Schedule II drugs. but are known to be'mixed in
specific ways to achieve a narCotic-like end product.
Schedule V dru&,S are available over the counter. '
Prescription drug abuse and drug monitoring programs
Excluding alcohol, prescription drugs are the second mos,t
commonly abused substance, after marijuana, according to a
2007 study by the Substance Abuse and Mental Health
Services Administration. The National Survey on Drug Use
and Health estimates tbat 20 to 30 percent ofCalifornia's
drug abusers primarily use prescription drugs, and a 2005
survey by the Drug Abuse Warning Network'estimates that
non-medical use of pharmaceuticals accounted for more than
half a million emergency room visits in the state. The DOJ
reports that Valium, ViC<><Jm; and Oxycontin are the most
prevalent pharmaceutical drugs obtained fraudulently. and
Vicodin and Oxycontin are the two most abuused phannaceutical
drugs in the United States.
Most states use Prescription Drug Monitoring Programs to
, help regulatory and law enforcement agencies and public
health officials collect and analyze controlled substance
prescription data. Statewide databases contain information
from phannacists and other prescribers on drugs 4ispensed
in the state.
According to the National Conference of State Legislatures,
as oflate 2010, 40 states bad laws establishing tbe
monitoring programs, and 33 states were operating such
programs. The programs vary in how they identify and
investigate potential abuse. Some are reactive,
hea1th-oriented monitoring programs that' generate reports
only in response to specific inquiries.

,

.

Other states
identify ,and investigate cases, as well as unsolicited reports
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when suspicious behavior is detected
Controlled Substance Utilization Review and Evaluation
System (CURES)
,
,'
Since 1940, DO] has maintained a state database of
dispensed prescription drugs with • high potential for
misuse. This infonnation is currently stored in the CURES
program, which contains over 100 million entries of .
controlled substance drugs that have been dispensed in
California. Each year the CURES program responds to more
that 60,000 requests from authorized practitioners and
pharmacists for patient prescription history illfo,rmatlon.
, In September of 2009, the Attorney General launched the
Prescription Drug Monitoring Program (PDMP) system allowing ,
pre-registered users, including licensed health care
. prescribers eligible to prescribe controlled substances,
pharmacists authorized to dispense controlled substances,
law enforcement, and regulatory boards, to access ~-time
patient controlled substance history information through a
secure website. Prior to adoption of PDM:P, doctors and
pharmacists had to request information by fax, mail o.r
phone, and wait days for a response. A $1.1 million
federal grant and edditionaJ state resources were used to
develop the new system. Under the systc;m. a registered
person authorized to prescribe or dispense a controlled
substance is able t.o instantly look up a new patient's
controlled s.ubstance history to determine whether the
patient legitimately needs medication or is doctor
shopping, the act of visiting several doctors to obtain
multiple prescriptions for drugs. The system also assists
. persons authorized to prescribe or dispense controlled
substances to assure patient safety. .
In order to obtain access to the system, authprized persons
must first register with CURES by submitting an application
and notarized doc~entation including: Drug Eriforcement
AdminiStration Registration, State Medical License or State
Phannacy License, and a government issued identification.

While all persons authorized to prescribe or dispense
controlled substances must submit information to be entered '
into the system, a very smal1 percentage of these persons
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are availing themselves of the database when it comes to
checking patient history before a prescription is written
or dispensed. According to DOl, out of the 185,000 Persons
authorized to write or dispense controlled. substances. a .
total of 5,434 have registered to access the database and
to date, 2,458 have been approved, others m~y be pending
additional information, notary, documentation, or
confirmation.
Dissemination or distribution ofPDMP information to. anyone
other than the registered user is strictly prohibited.
Disciplinary, civil or criminal actions are taken by the
DOl and/or appropriate Regulatory Board for any misuse or
inappropriate accessing of patient data. HlPAA·and all
confidentiality and disclosure provisions of California law
cover the information contained in this database, which
includes the .patient's dispensed drug record, including
drug name; date filled; quantity, strength and number of
refills; pharmacy name and license number; doctor's name
and DEA number; and, prescription number.
In 2008, the Attorney General and the CURES team targeted
the top 50 doctor shoppers in the state, who averaged mor.e
than 100 doctor and phannacy visits to collect massive
quantities of addictive drugs like Valium, Vicodin, and
Oxycontin. The crackdown led to the.arrest of dozens of
suspects.
CURE.S also alerts law enforcement and lice~ed medical
professionals to signs of illegal drug diversions. In
2008. the Attorney General and the Simi Valley Police
Department conducted a drug-trafficking investigation
which revealed a conspiracy in which stolen identities of
eight doctors were used to illegally write prescriptions.
'The drug ring also stole the identities of dozens of
citizens in order to fill the fraudulent prescriptions, and
were able to obtain more than 11,000 pills for drugs like
Oxycontin and Vicodin. In May 2009, the CURES team worked
with the Ventura County Sheriffs Office to provide
detectives with the prescribing history of a Burbank doctor
accused of writing hundreds of fraudulent prescriptions.
.
Seven of his patients died from prescription-<irug
overdoses.
Following an investigation, that included the
CURES report of the prescriptions he had written, the
doctor faced criminal charges, lost his medica1license and
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surrendered his license to prescribe controlled substances.
Current funding for CURES
According to documentation provided by DO], costs oftbe
CURES program in the current year are funded from the
following sources:
$379,432.17 from the General Fund for personnel
salary and benefits; and
$296,000 from the Department of Conswner Affairs
Bo~ds for data qollection, software licenses, and
department IT functions, ($10,000 - Nursing Board,
·$92,000 - Phannacy Board, $150,000 - Medical Board,
$4,000 - Osteopathic Medical Board, and $40,000 
Dental Board).
Additionally, a total of$9,1 02,323 in grant monies have
been awarded to the CURES program since 2003, as follows:
Bureau afU. S. Justice Administration:
$297,7452003 (2003), $350,000 (2004), 4000,000 (2006)
and $4000,000 (2007), primarily for staff and
onsultant time.
The Substance Abuse and Mental Health Services
Administration: $454,578 (2009).
CURES has also submitted an application for Bureau of
Justice Funds for 2010.
Prior legislation

SB 734 (Torlakson), Chapter 487, Statutes of2005,
authorized new tamper-resistant prescription pads and
permitted online access to CURES, pending the acquisition
of private fwlding:
SB 151 (Burton), Chapter 406, Statules of2003, elintinates
the sunset on the CURES program, eliminates the requirement
that Schedule IT controlled substances prescriptions be
written on triplicate forms, adds a requirement that
Schedule ill controlled substances be included in CURES.
AB 2655 (Matthews), Chapter 345, Statutes of 2002, extended
the sunset date of!):te CURES program by five years.
Permits a licensed health care practitioner to make
? written request of the DOJ for the history of controlled
substances dispensed to
individual. and permits DOJ to
provide the history of controlled substances dispensed to

an
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an individual to licensed health care practitioners and
pharmacists.
SB 1000 (Johannessen) 2001 would have allowed 0
practitioner eligible to obtain triplicate prescription
forms for Schedule D coritrolled substances or a phannacist
to request the history ofcontrolled substances dispensed
to an individuaJ under his or her care based on data
contained in CURES. This bill was vetoed by the Goyernor.
AB 2018 (Thompson), Chapter 1092, Statutes of2oo0, revised

prescription requirements for _Schedule n controlled
substances by permitting practitioners to receive more than
100 triplicate prescription blanks in • 30-doj period as
we1l as other changes.
SB 1308 (Committee on Business and Professions), Chapter
655, Statutes of 1999, extended the CURES pilot project by
three years and requires DOJ to snbmit annual status
reports on the program to the Legislature.
AB 2693 (Migden), Chapter 789, Statutes of 1998, exempts
prescriptions foi Schedule II contro1led substances for

patients with aterminal illness from triplicate
prescription form requirements in existing law.
AB 3042 (Takasugi), Chapter 738, Statutes ofl996, required

DOJ, contingent on the availability of funds, to establish
CURES for electronic monitoring of the prescribing and
dispensing of Schedule n controlled substances by 011
practitioners authorized to prescribe or dispense these
qontralled substances as a three-year pilot program.
An act to amend Section 11165 of, and to add and repeaJ Section

I Jl65.05 of, the Health and Safety Code, and to add and repeal SeCtion
17054.8 of, and to add and repeal Part 33 (commencing with Section
70001) of Division 2 of, the Revenue and Taxation Code, relating to
prescription drugs t8xation, to take effect immediately. tax levy.
.

Existing law imposes various taxes, including taxes on the privilege .
of engaging in certain .activities. The Fee Collection Procedures Law,
. the violation of which is a crime, provides procedures for the collection
of certain fees and surcharges.
.
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Existing law also requires the Department
of Justice to maintain the Controlled Substance Utilization Review and
Evaluation System (CURES) for the electronic monitoring of the
prescribing and dispensing of Schedule n, Schedule ill, and Schedule
IV controlled substance$ by all practitioners authorized to prescribe or
dispense these controlled substances.
This Proposition would, on and after JanuarY 1.. 2.013, impose a tax at the
rate of $0.0025 per pill included in
Schedu1~ II, IiI, or IV upon every manufacturer and importer of controlled
substances classified as Schedule II.
or IV, or other person that
makes the first sale in this state of a Schedule II, m, orTV controlled
substance. The uix would be administered by the State Board of
Equalization and would be collected pursuant to the procedures set forth
in the Fee Collection Procedures Law.

m.

The Proposition would requiie the board to deposit all taxes, penalties. and
interest collected, less refunds and administrative costs, in the CURES
Fund., which this Proposition would create. This PropositioD would require moneys in
.the fund, upon appropriation by the Legislature, to be ailocated to the
Department of Justice for the cost of administration of the CURES
program, as specified.
This Proposition would also require a person that manufactures co,ntrolled
substances classified in Schedule II,
or IV in this state, or that
imports controlled substances classified in Schedule II. m, or N into
this state, to register ·with the Department of Justice to enable the
department to report specified information to the board for purposes of
collecting a tax on those persons.

m.

Because this Proposition would expand the application of the Fee Collection
Procedures Law, the violation of which is a crime, it would impose a
state-mandated local program:
The California Constitution requires the state.to reimburse local
agencies and school districts for certain costs mandated by the state.
Statutory provisions establish procedures for making that r.eimbursement.
This Proposition would provide that no reimbursement is ~quired by this act
for a specified reason.
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This proposition would take effect immediately as a tax levy.
1 we find:

2 following examination:
3 (a) The CURES program is a valuable investigative, preventive,
4 and educational tool for law enforcement, regulatory boards,
educational researchers, and the health care community.
6 (b) Each year the CURES program responds to more than 60,000

7 requests from practitioners and phannacists to (1) help identify
8 and deter drug abuse and diversion through atcurate and rapid
9 tracking of Schedule n, ill, and IV controlled substances, (2) help
practitioners make better prescribing. decisions, and (3) cut down
11 on the misuse, abuse, and trafficking of prescription drugs in
12 California.
13 (c) The manufacture and importation of Schedules n, ill, and

14 IV controlled substances have had deleterious effects on private
and public interests, includlng the misuse, abuse, and trafficking
16 in dangerous prescription medications resulting in injury and death.
17 The tax that is imposed by this bill on manufacturers and importers .
18 of Schedules ll, ill, and !V.controlled substances seeks to mitigate
19 these effects of the drugs by supporting the operation of the

CURES program, which has proved a cost..etfective tool to help
21 to reduce the misuse, abuse, and trafficking of t)lose drugs.
22 (d) It is the nature of these Schedule n, ill, and IV controlled

23 substances that their addictive qualities and the ever present market
24 for their misuse and abuse pose inherent risks to public health that
mUst be systematically addressed, as by the CURES program.

26 Once these products are present in California, ad hoc enforcement
27 of conditions on distribution and criminal and civil sanctions on
28 downstream actors in the distribution system are extraordinarily
29 co.,tly. ineffective, and inefficient means, to attempt to control the
misuse, abuse, and trafficking of these substances. It is therefore
31 appropriate for manufacturers and importers, which benefit from

32 the commercial markets for these inherently dangerous products
33 with knowledge of their potential'for misuse and abuse absent
34 systematic tracking and monitoring, to pay for the cost-effective
CURES program.
.
36 SEC. 2. Section 11165 of the Hcalth and Safety Code is

11165. (a) To assist law enforcement and regulatory agencies
in their efforts to control the diversion and resultant abuse of
Schedule n, Schedule ill, and Schedule IV controlled substances,
and for statistical analysis, education, and research, the Department
. of Justice shilll, contingent upon the availability of adequate funds .
fr9ID the CURES Fund and from the Contingent Fund of the
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Medical Board of California, the Phamiacy Board Contingent
Fund, the State Dentistry Fund, the Board of Registered Nursing
Fund, and the Osteopathic Medical Board of California Contingent
Fund, maintain the Controlled Substance Utilization Review and
Evaluation System (CURES) for the electronic monitoring of the
prescribing and dispensing of Schedule IT, Schedule ill, and .
Schedule IV controlled substances by all practitioners authorized '
to prescribe or dispense these controlled substances.
.
(b) The reporting of Schedule ill and Schedule IV controlled
substance prescriptions to CURES shall be contingent upon the
availability of adequate funds D:om the Department of Justice. The

Department of Justice may seek and use grant funds to pay the
costs inc~ from the"reporting of controlled substance
prescriptions to CURES. Funds shall not be appropriated from the
Contingent Fund of the Medical Board ofCalifornia, the Pharmacy
Board Contingent Fund, the State Dentistry Fund, the Board of
Registered Nursing Fund. the Naturopathic Doctor's Fund, or the
Osteopathic Medical Board of California Contingent Fund to pay
the costs of reporting Schedule ill and Schedule IV controlled
substance prescriptions to CURES.
.
(c) CURES shall operate under existing provisions of law to
safeguard the privacy and confidentiality of patients. Data obtained
from.CURES shall only be provided to appropriate suite, local,
and fedCral 'personS or public agencies for disciplinary, civil, or
criminal purposes and to other agencies or entities, as determined .
by the Department 'of Justice, for the p~se of ed~cating
practitioners ap.d others in lieu of disciplinary, civil, or criminal
actions. Data may be provided to public or private entities, as
approved by the Department of Justice, for educational, peer
review. statistical, or research purposes, provided that patient
information, including any information that may identify the
patient, is not cotI?-promised. Further, data disclosed to any
individual or agency as described in this ~ubdivision shall not be
disclosed, sold, or transferred to any third party.

(d) For each prescription for a Schedule II, Schedule ill, or
Schedule IV controlled substance, the dispensing pharmacy or
clinic shall provide the following information to the Department
of Justice on a weekly basis and in a format specified by the
Department of Justice:
(1) The full name, address, and telephone number of the ultimate.
user or research subject, or contact information as detennined by
the Secretary of the United Staies Department of Health and Human
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, Services, and the gender and date of birth of the ultimate user.
(2) The prescriber's category of licensure and license number;
federal controlled substance registration number; and the state
medical license number ofany prescriber using"the federal
controlled substance registration number of a government-exempt
facility.
.
(3) Pharmacy prescription number, license number, and federal
controlled substance.registration number.
(4) NDC (National Drug Code) number of the controlled
substance dispensed.
(5) Quantity ofthe controlled substance dispensed.
(6) ICD-9 (diagnosis code), if available.
(7) Number of refills ordered.
(8) Whether the drug was dispensed as a refill of a prescription
or as afirst-time request. "
(9) Date of origin ofthe prescription.
(10) Date ofdispensing of the prescription.
SEC. 3. Section 11165.05 is added to the Health aod Safety
Code, to read:
11165.05. (a) A person that mannfactures controlled substaoces
classified in Schedule II, Ill, or IV in this state, or that imports
controlled substances classified in Schedule n, m, 'Of N into this
state, shall register with the Department of Justice to enable the
department to report to the State Board of Equalization the persons
subject to this section and to the tax imposed pursuant to Part 33
(commencing with Section 70001) of Division 2 of the Revenue
and Taxation Code.
(b) A person shall not sell or distribute any controlled substance
·classified in Schedule n, III, or IV in the state if the product is

received or purchased from a manufacrurer or importer that is not
registered in accordance with'the requirements of this section.

(b) A person required to register with the department sball file

an annual report with the department. The annual report shall be
due on or before January 1,2013, and on or before January 1 each
year thereafter, and shall provide the name, address, and telephone
number of the person required to register.
(d)
"(c) A person'.required to register with the department shall also
file a quarterly report with the department. The quarterly report
shall be due.on the last day oftbe month following eacb quarterly
period and shall provide all of the following infonnation:
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:

(1) The number of Schedule IT, m, or IV pills the registrant bas
sold in this state during that quarterly reporting period.
(2) The number of Schedule IT, Ill, or IV pills the registrant bas
imported into this state during that quarterly reporting periOd.
(3) The number of Schedule IT, m,"or IV pills the registrant has
sold, transferred, or otherwise furnished to other persons in this
state during that quarterly reporting period.
(4) Any other information the department deems necessary for
the purpose of administering this section.
(e)

(d) Each registrant that is required to provide the information
required by this section may be subject to audit by the department.
(f)
(e) On the last.day of each month foJlowing the due date for
filing a quarterly report pursuant to subdivision (d), the department
shaJl send to the state Board ofEquaJization a report containing
all of the following information:
(1) The name, address, and telephone number of each person
required to register with the department pursuant to this section,
and the necessary information regarding who OW~ the tax imposed,'
pursuant to Part 33 (commeocing with Section 70001) of Division
2 of the Revenue and Taxation Code on each Schedule IT, Ill, or
IV pill sold in this state in the amount of $0.0025 per pill for the
previous quarterly period.
(2) The number of Scbedule IT, m, or IV pills each registrant
.manufactured in this state or imported into this state.

CONTROLLED SUBSTANCES TAX LAW

.

70001. This part shaJl be lmown and may be cited as the
ControJled Substances Tax Law.
70002. For purposes oftbis part:
(a) "CURES program" means the ControUed Substance
Utilization Review and Evaluation System program described in
Section 11 I65 of the Health and Safety Code.
(b) "Importer" means a person "that imports controJled substances
classified in Schedule II, m, or IV into this state,. for sale or
distribution in this state.
(c) "Manufacturer" means a person that manufactures controlled
substances clas;ified in Schedule II, m, or IV sold in this state,
either directly or indirectly.
(d) "Quarterly report" means the report that a registrant is
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required to file with the Department of Justice pw-suant to Section .
11165.05 of the Health and Safety Code.
Ce) "Registrant1' means a maqufacturer or importer ofcontrolled
substances classified in Schedule II, III, or IV that is required to
annually register and report certairi. information to the Department
of Justice pursuant to Section 11165.05 of the Health and Safety
Code.
70003. On and after January 1,2013, a tax is hereby imposed
at the rate of$0.0025 per pill included in Schedule II, m, or IV
upon e~exy manufacturer and importer of controlled substances
classified as Schedule II, m, or N, or other person that makes the
first sale in this state of a Schedule II, m, or IV controlled
substance. The tax imposed by this part is for the purpose of
reimbursing the Department of Justice for the cost ofadministering
the CURES program, which provides for the electronic monitoring
of the prescribing and dispensing of controlled substances classified
in Schedule II, m, or IV.
70004. The board shall administer and collect the tax imposed
by this part ptirsuant to 'the Fee Collection Procedures Law (part
30 (commencing with Section 55001)). For purposes of this part,
the references in the Fee Collection Procedures Law to "fee" shall
include the tax imposed by this part and references to "feepayer"
shall include a persnn required to pay the tax imposed by this part.
70005. Each persnn required to pay the tax shall prepare and
file with the board a return in the form prescribed by the board
containing infonnation as the board deems necessary or appropriate
for the proper administration ofthis part. The return shall be filed
. on or before the last day of the calendar mC?nth·following the

calendar quarter to which it relates, together with a remittance
payable to the boam for the amount of tax due for that period.
70006. The board may prescribe those forms and reporring
requirements as are necessary to implement the tax, including, but
Dot limited to, information regarding the total amount·oftax due.
70007. (a) (I) The CURES Fund is hereby created in the State
Treasury. The CURES Fund shall consist of all taxes, interest,
penalties, and other amounts collected pursuant to this· part, less
refunds and reimbursement to the board for expenses incurred in
the adrilinistration and collection of the tax.
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(2) Money in the CURES Fund shall, upon appropriation by the
Legislature, be used to reimburse the Franchise Tax Board for
administrative costs related to Section 17054.8.
.
(b) All moneys in the CURES Fund less refunds and
reimbursement pursuant to subdivision (a), shall, ,upon
appropriation by the Legislature, be allocated to the Department
ofJustice for the following;
(I ) The cost of the administration of the CURES program as
required by this section and Section 11165.050ftIie Health and
Safety Code.
.
(2) The·cost of the maintenance of, and any improvements to,
the CURES program.
(3) The cost of education and outreaeb relating to the CURES
program.
.
(4) The cost of the investigation of abuses of the CURES
program.
70008. This part shall remain in effeci only until January I,
2016, and as of that date is repealed.
.sEC. 6. No reimbursement is required by this act pursuant to
Section '6 ofArticle XIllB of the California Constitution because
the.only costs that may be incurred by a loeal agency or school
district will be incuITed because this act creates a new crime.or
infractio~ eliminates'a e:rime or ~ction, or changes the penalty
for a crime or infraction, within the m~g ofSection 17556 of
the Government Code, or changes the d~finition ofa crlme .within
the meaning of Section 6 ofArticle xm B ofthe California
Constitution.

SEC. 7, This Proposition provides for a tax levy within the meaning of
A,rticle N of the Constitution and shaH ,go into immediate effect.
###

Page 15

. .

